Please login to the form below

Not currently logged in

Alexion begins work on new global headquarters

Rare diseases drug company will move to new US site in 2015

Alexion Pharmaceuticals New Haven ground breaking
From left: New Haven Mayor John DeStefano, Sen. Richard Blumenthal, Governor Dan Malloy, Alexion CEO Leonard Bell, Rep. Rosa Delauro and Yale University VP Bruce Alexander (photo: Business Wire)

Alexion Pharmaceuticals has broken ground on the site for its new global headquarters in New Haven, Connecticut.

The rare diseases specialist will occupy nine floors at the College Street site and expects to move across the state from its current Cheshire base to take residency at the site in 2015.

Leonard Bell, chief executive officer of Alexion, said: "Our new global headquarters will support our continued growth as we work to develop and deliver life-transforming therapies for patients with severe and life-threatening disorders that are also ultra-rare.

“We are especially pleased by this step because our return to New Haven is a homecoming for our company, and we are able to take part in the redevelopment of the downtown area.”

Alexion was founded 20 years ago in New Haven and currently employs more than 400 people at its present Connecticut site.

Sales of its lead terminal complement inhibitor Soliris (eculizumab) last year topped $1.1bn and asfotase alfa, its treatment for the inherited metabolic disorder hypophosphatasia that last month received breakthrough status from the FDA, could give the company a second big-selling product.

Once the company's new HQ is ready they will be relocated to New Haven, where Alexion plans to add up to another 300 new jobs as part of its expansion plans.

Article by
Dominic Tyer

19th June 2013

From: Research, Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...